According to a recent Mayo Clinic-led study, most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer.
A Mayo Clinic study has found a diagnostic test based on chromosomal rearrangements can trace the lineage of lung cancer to determine whether two separate lung cancers in the same patient are independent tumors or a tumor that has spread to another region of the lung. For patients with multiple tumors, that distinction could mean the difference between early stage cancer that may be cured by surgery and incurable late-stage disease.
Hunterdon Healthcare has selected Mayo Medical Laboratories, which will give them access to our extensive menu of laboratory tests and clinical expertise.
GenomeDx Biosciences today announced that the company has expanded its research agreement with Mayo Clinic to initiate a validation study to expand the use of the Decipher® Prostate Cancer Classifier, a genomic test capable of predicting metastatic prostate cancer, for use in prostate biopsy specimens.
The International Myeloma Working Group (IMWG) announced that it has updated the criteria for diagnosing multiple myeloma. Mayo Clinic hematologist, S. Vincent Rajkumar, M.D., is the lead author on a paper, which outlines the new criteria.
Shore Medical Center (SMC) has selected Mayo Medical Laboratories as its primary reference laboratory. Based in Somers Point, N.J., Shore Medical Center will continue to conduct most of its own inpatient and outpatient testing, but will leverage its collaboration with Mayo Medical Laboratories to access to more advanced diagnostic and newly developed tests.
Advanced Biological Laboratories, S.A, and Mayo Medical Laboratories have announced a collaboration agreement to develop a deep-sequencing pipeline for novel diagnostic laboratory-developed tests.
Due to the Labor Day holiday, observed Monday, Sept. 1 in the United States, Mayo Medical Laboratories’ specimen pickup and delivery schedule will be altered. To ensure that your specimen vitality and turn-around time are not affected, plan ahead and note that no pickups or deliveries will be made on Sept. 1 by our couriers or FedEx.
Mayo Clinic has achieved the highest honor in U.S. News and World Report’s ranking of top hospitals. Mayo Clinic earned more number one rankings than any other provider, ranking number one or number two in 11 of the 12 specialties based on reputation, services and volumes, safety and clinical outcomes.
Summer fun often includes hiking, biking, and just enjoying the great outdoors. But hanging out in parks or walking on trails also invites ticks to hop a ride. Read this post to learn four tips from the Mayo Clinic Parasitology Laboratory for arming yourself against these unwanted visitors.
Independence Day, observed on Friday, July 4, is a U.S. national holiday. Due to the holiday, Mayo Medical Laboratories’ specimen pickup and delivery schedule will be altered. To ensure that your specimen vitality and turn-around time are not affected, plan ahead and note that no pickups or deliveries will be made on July 4 by our couriers or FedEx.
N-of-One, the leading provider of clinical interpretation for precision medicine in oncology, will provide Mayo Clinic access to clinical interpretation information to aid in highly complex molecular diagnostics.
Mayo Clinic and Mayo Medical Laboratories announce the launch of CANCP, a new gene panel cancer test to help tailor therapies to the individual patient based on the unique genomic signature of the patient’s tumor.